The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score -1.82 — distress zone — historically elevated failure riskWatch
- Earnings-manipulation signal · Beneish M -2.90 — no flag raisedOK
- Earnings quality 83/100 — accruals in line with cashOK
Where the revenue comes from
Fiscal 2025, as ANGIODYNAMICS INC reports it. History and quarterly detail are in the app.
- Med Device$165.8M
- Med Tech$126.7M
Leadership changes
From ANGIODYNAMICS INC's own filings, the day they're filed.
- Wesley Johnson · director · departureeff. 2024-02-08
- Jan Stern Reed · director · departureeff. 2024-02-08
- Lorinda Burgess · director · appointment
Latest filings
- 8-K · Company announcement2026-04-23
- 10-Q · Quarterly report2026-04-02
- 8-K · Company announcement2026-04-02
- 8-K · Company announcement2026-02-03
- 8-K · Company announcement2026-01-14
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, every figure source-linked🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask anything about ANGIODYNAMICS INC, every answer cited🔒
- The Intelligence Brief — added when ANGIODYNAMICS INC's brief passes our SEC-figure check🔒
Every figure links to the filing it came from, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.